Kalanke v Freie Hansestadt Bremen

EQS-News: DFV Deutsche Familienversicherung AG implements Executive Management Team

Retrieved on: 
Thursday, February 2, 2023
Online, General Dynamics, DFV, Rejuvenation, Kalanke v Freie Hansestadt Bremen, University, CIO, Insurance, EMT, Technische Universität Darmstadt, Security, West Coast of Vancouver Island Aquatic Management Board, Deutsche Post, Claim, Head, Federal Ministry of the Interior, Building and Community, Frankfurt, Germany, Automation, Chancellor of Germany, Lord Chancellor's Department, Department of Computer Science of TU Darmstadt, Bundeswehr, Operation, Doctor of Philosophy, Information technology, Orientation, Management, Economics

Frankfurt am Main, 18 January 2023 – DFV Deutsche Familienversicherung AG (DFV) has appointed Bettina Hornung as Chief Information Officer (CIO) and Maximilian Knoll as Chief Operations Officer (COO).

Key Points: 
  • Frankfurt am Main, 18 January 2023 – DFV Deutsche Familienversicherung AG (DFV) has appointed Bettina Hornung as Chief Information Officer (CIO) and Maximilian Knoll as Chief Operations Officer (COO).
  • Both are members of DFV’s newly implemented Executive Management Team (EMT) with immediate effect, supporting the Management Board of Deutsche Familienversicherung.
  • Maximilian Knoll joined Deutsche Familienversicherung on 1 April 2022 and has since headed the newly created Operations and Claims department.
  • At the same time, the Management Board has appointed Bettina Hornung, previously Head of IT Governance, as Chief Information Officer of Deutsche Familienversicherung and appointed her as member of the Executive Management Team.

DGAP-News: Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer

Retrieved on: 
Thursday, June 23, 2022
Time, Sepsis, Dr. med. Sommer II, Public health, Drug development, Hope, Safety, INN, RTÉ Executive Board, CEO, Kalanke v Freie Hansestadt Bremen, Board of directors, Company, Glenmark Pharmaceuticals, LinkedIn, Septic shock, Schering AG, Lead, CMO, Faculty, Central nervous system, Twitter, AG, Patient, Jean-Louis Vincent, Pharmaceutical industry, Medicine

Steffen Strzebecher as Chief Medical Officer (CMO) of Adrenomed, effective June 20, 2022.

Key Points: 
  • Steffen Strzebecher as Chief Medical Officer (CMO) of Adrenomed, effective June 20, 2022.
  • Dr. Richard Jones, CEO of Adrenomed, said: We are excited to have Steffen Strzebecher on board to lead Adrenomeds clinical development activities.
  • Dr. Jens Zimmermann, CMO emeritus of Adrenomed, commented: After more than four years at Adrenomed I will be stepping down as Chief Medical Officer due to health reasons.
  • Dr. Strzebecher previously held several executive positions at Grnenthal, including Chief Medical Officer, Head R&D Portfolio Management, Head of Global Development, and Head of Global Medical Sciences.